[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2866571B1 - USE OF A MIXTURE OF SPECIFIC POLYSACCHARIDES AS INDICATED BY THE EZBONE INVENTOR COMPRISING HYALURONIC ACID, CHONDROID SULFATE, DERMATANE SULFATE AND HEPARIN IN BONE HEALING. - Google Patents

USE OF A MIXTURE OF SPECIFIC POLYSACCHARIDES AS INDICATED BY THE EZBONE INVENTOR COMPRISING HYALURONIC ACID, CHONDROID SULFATE, DERMATANE SULFATE AND HEPARIN IN BONE HEALING.

Info

Publication number
FR2866571B1
FR2866571B1 FR0401700A FR0401700A FR2866571B1 FR 2866571 B1 FR2866571 B1 FR 2866571B1 FR 0401700 A FR0401700 A FR 0401700A FR 0401700 A FR0401700 A FR 0401700A FR 2866571 B1 FR2866571 B1 FR 2866571B1
Authority
FR
France
Prior art keywords
sulfate
ezbone
chondroid
heparin
inventor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0401700A
Other languages
French (fr)
Other versions
FR2866571A1 (en
Inventor
Philippe Zanchetta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR0401700A priority Critical patent/FR2866571B1/en
Publication of FR2866571A1 publication Critical patent/FR2866571A1/en
Application granted granted Critical
Publication of FR2866571B1 publication Critical patent/FR2866571B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
FR0401700A 2004-02-20 2004-02-20 USE OF A MIXTURE OF SPECIFIC POLYSACCHARIDES AS INDICATED BY THE EZBONE INVENTOR COMPRISING HYALURONIC ACID, CHONDROID SULFATE, DERMATANE SULFATE AND HEPARIN IN BONE HEALING. Expired - Fee Related FR2866571B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0401700A FR2866571B1 (en) 2004-02-20 2004-02-20 USE OF A MIXTURE OF SPECIFIC POLYSACCHARIDES AS INDICATED BY THE EZBONE INVENTOR COMPRISING HYALURONIC ACID, CHONDROID SULFATE, DERMATANE SULFATE AND HEPARIN IN BONE HEALING.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0401700A FR2866571B1 (en) 2004-02-20 2004-02-20 USE OF A MIXTURE OF SPECIFIC POLYSACCHARIDES AS INDICATED BY THE EZBONE INVENTOR COMPRISING HYALURONIC ACID, CHONDROID SULFATE, DERMATANE SULFATE AND HEPARIN IN BONE HEALING.

Publications (2)

Publication Number Publication Date
FR2866571A1 FR2866571A1 (en) 2005-08-26
FR2866571B1 true FR2866571B1 (en) 2007-09-21

Family

ID=34833936

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0401700A Expired - Fee Related FR2866571B1 (en) 2004-02-20 2004-02-20 USE OF A MIXTURE OF SPECIFIC POLYSACCHARIDES AS INDICATED BY THE EZBONE INVENTOR COMPRISING HYALURONIC ACID, CHONDROID SULFATE, DERMATANE SULFATE AND HEPARIN IN BONE HEALING.

Country Status (1)

Country Link
FR (1) FR2866571B1 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7947784B2 (en) 2007-11-16 2011-05-24 Zimmer, Inc. Reactive compounding of hydrogels
US7985781B2 (en) 2004-10-12 2011-07-26 Zimmer Gmbh PVA hydrogel
US8017107B2 (en) 2005-12-22 2011-09-13 Zimmer, Inc. Perfluorocyclobutane crosslinked hydrogels
US8017139B2 (en) 2005-02-23 2011-09-13 Zimmer Technology, Inc. Blend hydrogels and methods of making
US8034362B2 (en) 2008-01-04 2011-10-11 Zimmer, Inc. Chemical composition of hydrogels for use as articulating surfaces
US8062739B2 (en) 2007-08-31 2011-11-22 Zimmer, Inc. Hydrogels with gradient
US8110242B2 (en) 2006-03-24 2012-02-07 Zimmer, Inc. Methods of preparing hydrogel coatings
US8236342B2 (en) 2007-08-03 2012-08-07 Zimmer, Inc. Multi-polymer hydrogels
US8262730B2 (en) 2005-12-07 2012-09-11 Zimmer, Inc. Methods of bonding or modifying hydrogels using irradiation

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2281265B1 (en) * 2005-11-24 2008-08-16 Bioiberica, S.A. COMPOSITIONS FOR THE TREATMENT OF ARTROSIS.
ES2304886B1 (en) * 2007-04-13 2009-11-11 Bioiberica, S.A. "COMPOSITIONS TO NUTRIR THE ARTICULATIONS".
AU2010328726B2 (en) * 2009-12-09 2017-01-19 Agency For Science, Technology And Research Glycosaminoglycan mixtures
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US8623839B2 (en) 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9402528D0 (en) * 1994-07-19 1994-07-19 Astra Ab Hard tissue stimulant with electricity
US6221854B1 (en) * 1996-03-05 2001-04-24 Orquest, Inc. Method of promoting bone growth with hyaluronic acid and growth factors
FR2811229B1 (en) * 2000-07-04 2003-08-01 Ifremer USE OF A POLYSACCHARIDE EXCRETED BY THE VIBRIO DIABOLICUS SPECIES IN BONE HEALING

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7985781B2 (en) 2004-10-12 2011-07-26 Zimmer Gmbh PVA hydrogel
US8017139B2 (en) 2005-02-23 2011-09-13 Zimmer Technology, Inc. Blend hydrogels and methods of making
US8262730B2 (en) 2005-12-07 2012-09-11 Zimmer, Inc. Methods of bonding or modifying hydrogels using irradiation
US8017107B2 (en) 2005-12-22 2011-09-13 Zimmer, Inc. Perfluorocyclobutane crosslinked hydrogels
US8110242B2 (en) 2006-03-24 2012-02-07 Zimmer, Inc. Methods of preparing hydrogel coatings
US8236342B2 (en) 2007-08-03 2012-08-07 Zimmer, Inc. Multi-polymer hydrogels
US8062739B2 (en) 2007-08-31 2011-11-22 Zimmer, Inc. Hydrogels with gradient
US7947784B2 (en) 2007-11-16 2011-05-24 Zimmer, Inc. Reactive compounding of hydrogels
US8034362B2 (en) 2008-01-04 2011-10-11 Zimmer, Inc. Chemical composition of hydrogels for use as articulating surfaces

Also Published As

Publication number Publication date
FR2866571A1 (en) 2005-08-26

Similar Documents

Publication Publication Date Title
FR2866571B1 (en) USE OF A MIXTURE OF SPECIFIC POLYSACCHARIDES AS INDICATED BY THE EZBONE INVENTOR COMPRISING HYALURONIC ACID, CHONDROID SULFATE, DERMATANE SULFATE AND HEPARIN IN BONE HEALING.
EP2305269A3 (en) Immunemodulating oligosaccharides
WO2007070547A3 (en) Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
EP2374362A3 (en) Use of polydextrose for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
DK1660458T3 (en) 2,4-Pyrimidine diamines useful in the treatment of neoplastic diseases, inflammatory disorders and disorders of the immune system.
NZ624749A (en) A sulfated polysaccharide compound and the preparation and use thereof
PT1809661E (en) Human interferon-beta mutein
DE50205968D1 (en) HEPARIN-CONTAINING OPHTHALMIC
DE602005027883D1 (en) 2-O, 3-O DESULFATED HEPARIN FOR THE TREATMENT OF HEPARINE-INDUCED THROMBOCYTOPENY (HIT)
ITPD20040245A1 (en) BIOMATERIALS MADE UP OF HYALURONIC ACID, SULFATE AND GELL, USABLE IN THE PREVENTION OF SPINAL ADHESIONS
PL375693A1 (en) Aldonic acid esters, methods for producing the same, and methods for producing pharmaceutical active ingredients coupled to polysaccharides or polysaccharide derivatives on free amino groups
EP1561760A3 (en) Low molecular weight heparin salt with thriethanolamine
UA35209U (en) Method for extension of human life
IL165807A0 (en) Process for preparing epimerized derivatives of k5polysaccharide with a very high degree of sulfati on and new epi k5-n,o-sulfated polysaccharide derivatives
WO2007059874A3 (en) Compositions for the treatment of osteoarthritis and to nourish the synovial fluid
WO2007097922A3 (en) Receptor-based blood detoxification system
FR2883181B1 (en) COMPOSITION BASED ON AVERMECTIN AND AZELAIC ACID, IN PARTICULAR FOR THE TREATMENT OF ROSACEA
ITTO20030126A1 (en) COMPOSITION OF FOOD SUPPLEMENT SUITABLE TO FAVOR THE ABSORPTION OF IRON.
CN204814711U (en) Passive form combination motion ankle joint rehabilitation ware
Sun et al. Research of China Economic Parks Based on Complexity Chaos Theory
BR8102420U (en) Toys for public squares, playgrounds and the like made from modules
RU2002104397A (en) THERAPY FOR THE TREATMENT OF ARTHROSIS
FR2798670B1 (en) LACTICAL BACTERIES TRANSFORMED TO PROVIDE THEM WITH BREATHING METABOLISM, AND LEAVES INCLUDING SAID BACTERIA
Melvin Still reinventing
FR2864089B1 (en) CHONDROID SULFATE CARBOXY-REDUCED DERIVATIVES, THEIR PREPARATION, THEIR APPLICATION AS MEDICINE AND THE PHARMACEUTICAL COMPOSITIONS COMPRISING THEM

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

ST Notification of lapse

Effective date: 20191006